Functional imaging after the “ISCHEMIA” trial
Archives of Cardiovascular Diseases · 2023
DOI: 10.1016/j.acvd.2023.08.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Cardiovascular Diseases, 2023. Verfasst von Suzanne Duhamel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Magnetic Resonance Laboratory, institut cardiovasculaire Paris Sud, hôpital privé Jacques-Cartier, Ramsay santé, 6, avenue du Noyer-La…. Hauptthemen laut MEDLINE: Predictive Value of Tests, Myocardial Ischemia, Coronary Angiography, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Previous randomized trials have shown a lack of benefits from the addition of revascularization to optimal medical therapy versus optimal medical therapy alone in patients with stable ischaemic heart disease at relatively low risk (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE]), and in diabetic patients with stable ischaemic heart disease (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetics [BARI 2D]). More recently, the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) randomized clinical trial showed similar results in patients with moderate-severe ischaemia on functional testing (imaging or stress electrocardiogram) and at least one significant (> 50%) coronary stenosis in a major epicardial coronary artery on coronarography computed coronary angiography. Although the ISCHEMIA trial adds pivotal knowledge regarding the management of and decision-making in stable patients, this study has prompted a great debate about the role of functional imaging for diagnosis, risk stratification and therapeutic decision-making. The objectives of this review are to summarize the results of the ISCHEMIA trial, to underline its limitations and to warn care providers about potential misinterpretation of this trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Magnetic Resonance Laboratory, institut cardiovasculaire Paris Sud, hôpital privé Jacques-Cartier, Ramsay santé, 6, avenue du Noyer-Lambert, 91300 Massy, France.
- Service de cardiologie, hôpital Lariboisière, AP-HP, université Paris cité, Inserm UMRS 942, 75010 Paris, France.
- Cardiovascular Magnetic Resonance Laboratory, institut cardiovasculaire Paris Sud, hôpital privé Jacques-Cartier, Ramsay santé, 6, avenue du Noyer-Lambert, 91300 Massy, France. Electronic address: jgarot@angio-icps.com.
Zitieren
APA
Duhamel, S., Pezel, T., & Garot, J. (2023). Functional imaging after the “ISCHEMIA” trial. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2023.08.002
Vancouver
Duhamel S, Pezel T, Garot J. Functional imaging after the “ISCHEMIA” trial. Archives of Cardiovascular Diseases. 2023. doi:10.1016/j.acvd.2023.08.002
BibTeX
@article{Duhamel2023,
author = {Duhamel, Suzanne and Pezel, Théo and Garot, Jérôme},
title = {Functional imaging after the “ISCHEMIA” trial},
journal = {Archives of Cardiovascular Diseases},
year = {2023},
doi = {10.1016/j.acvd.2023.08.002}
}
EUVIMED